HEADER LIGASE 24-JAN-07 2JNH TITLE SOLUTION STRUCTURE OF THE UBA DOMAIN FROM CBL-B COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE CBL-B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UBA DOMAIN; COMPND 5 SYNONYM: SIGNAL TRANSDUCTION PROTEIN CBL-B, SH3-BINDING PROTEIN CBL- COMPND 6 B, CASITAS B-LINEAGE LYMPHOMA PROTO-ONCOGENE B, RING FINGER PROTEIN COMPND 7 56; COMPND 8 EC: 6.3.2.-; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CBLB, RNF56; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET-32M KEYWDS UBA DOMAIN, CBL-B, LIGASE EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR C.ZHOU,Z.ZHOU,D.LIN,H.HU REVDAT 7 20-DEC-23 2JNH 1 REMARK REVDAT 6 14-JUN-23 2JNH 1 REMARK REVDAT 5 05-FEB-20 2JNH 1 REMARK REVDAT 4 24-FEB-09 2JNH 1 VERSN REVDAT 3 07-OCT-08 2JNH 1 JRNL REVDAT 2 15-JUL-08 2JNH 1 JRNL REVDAT 1 05-FEB-08 2JNH 0 JRNL AUTH Z.R.ZHOU,H.C.GAO,C.J.ZHOU,Y.G.CHANG,J.HONG,A.X.SONG,D.H.LIN, JRNL AUTH 2 H.Y.HU JRNL TITL DIFFERENTIAL UBIQUITIN BINDING OF THE UBA DOMAINS FROM HUMAN JRNL TITL 2 C-CBL AND CBL-B: NMR STRUCTURAL AND BIOCHEMICAL INSIGHTS JRNL REF PROTEIN SCI. V. 17 1805 2008 JRNL REFN ISSN 0961-8368 JRNL PMID 18596201 JRNL DOI 10.1110/PS.036384.108 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRDRAW 2.3, ARIA 2.0 REMARK 3 AUTHORS : DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER AND BAX REMARK 3 (NMRDRAW), LINGE, O'DONOGHUE AND NILGES (ARIA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2JNH COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000100053. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM [U-13C; U-15N] ENTITY, 20 REMARK 210 MM SODIUM PHOSPHATE, 50 MM REMARK 210 SODIUM CHLORIDE, 1 MM DTT, 0.01 % REMARK 210 SODIUM AZIDE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D CBCA(CO)NH; 3D C(CO)NH; 3D REMARK 210 HNCO; 3D HNCACB; 3D HCCH-TOCSY; REMARK 210 3D HNHA; 3D 1H-15N NOESY; 3D 1H- REMARK 210 13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY 3.110, ARIA 2.0, REMARK 210 PROCHECKNMR REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 250 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-15 REMARK 465 RES C SSSEQI REMARK 465 GLU A 1 REMARK 465 ALA A 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 4 -54.75 -149.84 REMARK 500 1 ASN A 6 -72.92 -117.91 REMARK 500 1 PHE A 45 -81.86 63.50 REMARK 500 2 ASN A 6 -62.80 -159.14 REMARK 500 2 ALA A 31 38.26 -83.05 REMARK 500 2 GLN A 32 -84.11 60.61 REMARK 500 2 ASN A 33 -5.82 -148.23 REMARK 500 2 GLU A 44 -73.41 -124.55 REMARK 500 2 PHE A 45 -21.89 -164.58 REMARK 500 3 PHE A 45 135.36 65.41 REMARK 500 4 LEU A 4 -85.70 58.53 REMARK 500 4 ARG A 43 -66.60 -92.06 REMARK 500 4 GLU A 44 -70.20 -50.35 REMARK 500 4 PHE A 45 -73.35 -55.71 REMARK 500 5 LEU A 4 -69.61 -100.88 REMARK 500 5 ALA A 31 32.49 -82.60 REMARK 500 5 GLN A 32 -76.68 65.36 REMARK 500 5 ASN A 33 19.50 -164.40 REMARK 500 5 GLU A 44 -73.41 -61.31 REMARK 500 6 ASN A 6 -54.20 -129.80 REMARK 500 6 ALA A 31 45.38 -81.05 REMARK 500 6 GLN A 32 -77.38 64.30 REMARK 500 6 ASN A 33 14.51 -161.46 REMARK 500 6 GLU A 44 -80.70 -125.89 REMARK 500 6 PHE A 45 -75.33 -174.10 REMARK 500 7 LEU A 4 -159.36 55.95 REMARK 500 7 ASN A 6 91.80 57.56 REMARK 500 7 ALA A 31 26.74 -77.01 REMARK 500 8 ALA A 31 30.12 -83.21 REMARK 500 8 GLN A 32 -81.42 65.09 REMARK 500 8 ASN A 33 25.41 -155.00 REMARK 500 8 GLU A 44 -80.32 -124.63 REMARK 500 8 PHE A 45 142.65 -171.74 REMARK 500 9 ASN A 6 -153.69 -109.32 REMARK 500 9 VAL A 24 -70.08 -65.20 REMARK 500 9 GLN A 32 -78.02 64.10 REMARK 500 9 ASN A 33 28.15 -157.16 REMARK 500 9 GLU A 44 -77.37 -126.10 REMARK 500 9 PHE A 45 12.12 -163.93 REMARK 500 10 LEU A 4 -60.50 -94.36 REMARK 500 10 ALA A 31 39.98 -81.79 REMARK 500 10 GLN A 32 -85.12 62.70 REMARK 500 10 ASN A 33 27.35 -151.97 REMARK 500 11 LEU A 4 -83.06 61.67 REMARK 500 11 ASN A 6 -59.67 -143.76 REMARK 500 11 ALA A 20 -176.73 -65.55 REMARK 500 11 GLN A 32 -72.97 69.07 REMARK 500 11 ASN A 33 19.37 -157.29 REMARK 500 11 PHE A 45 -174.36 59.88 REMARK 500 12 LEU A 4 -85.87 61.00 REMARK 500 REMARK 500 THIS ENTRY HAS 63 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 15111 RELATED DB: BMRB DBREF 2JNH A 1 46 UNP Q13191 CBLB_HUMAN 926 971 SEQRES 1 A 46 GLU ALA ALA LEU GLU ASN VAL ASP ALA LYS ILE ALA LYS SEQRES 2 A 46 LEU MET GLY GLU GLY TYR ALA PHE GLU GLU VAL LYS ARG SEQRES 3 A 46 ALA LEU GLU ILE ALA GLN ASN ASN VAL GLU VAL ALA ARG SEQRES 4 A 46 SER ILE LEU ARG GLU PHE ALA HELIX 1 1 ASN A 6 GLY A 16 1 11 HELIX 2 2 ALA A 20 ALA A 31 1 12 HELIX 3 3 ASN A 34 ARG A 43 1 10 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1